Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Cancer
|
January 13, 2010
Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?
Roderick C N van den Bergh, Ewout W Steyerberg, Ali Khatami, et al.
European Urology
|
August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort
Andrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
European Urology Open Science
|
December 22, 2021
Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
Rebecka Arnsrud Godtman, Sebastiaan Remmers, Gunnar Aus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2015
Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening
Anssi Auvinen, Sue M Moss, Teuvo L J Tammela, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
The New England Journal of Medicine
|
March 20, 2009
Screening and prostate-cancer mortality in a randomized European study
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
European Urology
|
August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Lancet (London, England)
|
August 11, 2014
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Cancer
|
January 13, 2010
Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?
Roderick C N van den Bergh, Ewout W Steyerberg, Ali Khatami, et al.
European Urology
|
August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort
Andrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
European Urology Open Science
|
December 22, 2021
Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
Rebecka Arnsrud Godtman, Sebastiaan Remmers, Gunnar Aus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2015
Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening
Anssi Auvinen, Sue M Moss, Teuvo L J Tammela, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
The New England Journal of Medicine
|
March 20, 2009
Screening and prostate-cancer mortality in a randomized European study
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
European Urology
|
August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Lancet (London, England)
|
August 11, 2014
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
Page
of 7